Browse studies

Find your next paid study

330 recruiting studies matching your filters

A Phase I Trial of Stereotactic HYpofractionateD RadioAblative (HYDRA) Treatment of Laryngeal Cancer

To find the highest tolerable dose of stereotactic hypofractionated radioablation (HYDRA) radiation that can be given to patients with laryngeal cancer. The sa…

Malignant Neoplasms of Respiratory and Intrathoracic OrgansSquamous Cell Carcinoma of the Larynx

Estimated

~$10 – $6,250

M.D. Anderson Cancer CenterNCT03114462

Phase 1

A Phase I Trial of Intraperitoneal Mesothelin-Targeted CAR T-Cell Therapy in Patients With Mesothelin-Positive Esophagogastric Adenocarcinoma With Peritoneal Carcinomatosis

Participants will have a sample of their white blood cells, called T cells, collected using a procedure called leukapheresis. The collected T cells will be sen…

Mesothelin PositiveMesothelin-Expressing TumorsEsophageal Adenocarcinoma+5 more

Estimated

~$10 – $6,250

Memorial Sloan Kettering Cancer CenterNCT06623396

Phase 1

A Phase 1/2, Open-label Clinical Trial to Evaluate Safety and Efficacy of Combination Paclitaxel and BMX-001, in Adult Patients With Advanced, Recurrent, Metastatic Ovarian or Endometrial Cancer

This research project addresses the urgent need for novel therapeutic strategies to overcome chemotherapy resistance and mitigate chemotherapy-induced peripher…

Ovarian NeoplasmsEndometrial Cancer, Endometrial Neoplasm

Estimated

~$10 – $8,750

BioMimetix JV, LLCNCT06620029

Anastrozole Adjuvant Trial - Study of Anastrozole Compared to NOLVADEX (Tamoxifen Citrate) for Adjuvant Treatment of Early Breast Cancer (Clinical Studies), Tamoxifen Citrate Was Added to Adjunct Cytotoxic Chemotherapy- Treatment of Malignant Joint Tumor.

At a median follow-up of 33 months, the combination of anastrozole and NOLVADEX (tamoxifen citrate) did not demonstrate any efficacy benefit when compared to N…

Metastatic Breast CancerTumorMuscle Neoplasms+1 more

Estimated

~$10 – $1,125

DR. DIANE CHISESI NFS. MD. PHD.NCT06154590

Phase 1

A Prospective, Open-Label, Single-Arm Pilot Study to Evaluate the Safety and Efficacy of Bevacizumab in Combination With NaviFUS System for the Treatment of Recurrent Glioblastoma Multiforme (rGBM)

This will be a prospective, open-label, single-arm pilot study to investigate the safety and efficacy of Bevacizumab (BEV) in combination with microbubble (MB)…

Glioblastoma MultiformeGlioblastomaGlioma+3 more

Estimated

~$10 – $8,750

NaviFUS CorporationNCT06329570

Phase 3

A Phase 3, Open-Label, Randomized Study of Perioperative Dostarlimab Monotherapy Versus Standard of Care in Participants With Untreated T4N0 or Stage III dMMR/MSI-H Resectable Colon Cancer

The primary purpose of this study is to evaluate the efficacy of perioperative dostarlimab compared with standard of care (SOC) in participants with untreated …

Colonic NeoplasmsNeoplasms, Colon

Estimated

~$10 – $7,500

GlaxoSmithKlineNCT05855200